| Autor: |
Mamatha, Pasnoor, Mazen M, Dimachkie, Patricia, Kluding, Richard J, Barohn |
| Rok vydání: |
2013 |
| Předmět: |
|
| Zdroj: |
Neurologic clinics. 31(2) |
| ISSN: |
1557-9875 |
| Popis: |
Diabetes is the most common cause of neuropathy in US and neuropathies are the most common complication of diabetes mellitus affecting up to 50% of patients with type 1 and type 2 diabetes mellitus. Various types of neuropathies can be associated with diabetes mellitus.1 Symptoms usually include numbness, tingling, pain and weakness. Dizziness with postural changes can be seen with autonomic neuropathy. Metabolic, vascular and immune theories have been proposed for the pathogenesis of diabetic neuropathy. Pathologically axonal damage and segmental demyelination can be seen with diabetic neuropathies. Management of diabetic neuropathy should begin at the initial diagnosis of diabetes and mainly requires tight and stable glycemic control. Many medications are available for the treatment of neuropathic pain. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
